h1

001007642 001__ 1007642
001007642 005__ 20250729052036.0
001007642 0247_ $$2HSB$$aeva578696
001007642 0247_ $$2ISSN$$a0006-5242
001007642 0247_ $$2ISSN$$a0939-5555
001007642 0247_ $$2ISSN$$a1432-0584
001007642 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85198916761
001007642 0247_ $$2WOS$$aWOS:001271492200001
001007642 0247_ $$2doi$$a10.1007/s00277-024-05851-4
001007642 0247_ $$2pmid$$apmid:39023573
001007642 0247_ $$2datacite_doi$$a10.18154/RWTH-CONV-254025
001007642 037__ $$aRWTH-CONV-254025
001007642 041__ $$aEnglish
001007642 1001_ $$aLipton, Jeffrey H.$$b0$$eCorresponding author
001007642 245__ $$aPractical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia$$honline
001007642 260__ $$aBerlin ; Heidelberg ; New York$$bSpringer$$c2024
001007642 3367_ $$00$$2EndNote$$aJournal Article
001007642 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
001007642 3367_ $$2BibTeX$$aARTICLE
001007642 3367_ $$2DRIVER$$aarticle
001007642 3367_ $$2DataCite$$aOutput Types/Journal article
001007642 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001007642 591__ $$aCanada
001007642 591__ $$aGermany
001007642 591__ $$aUK
001007642 591__ $$aUSA
001007642 7001_ $$0P:(DE-82)IDM06025$$aBrümmendorf, Tim Henrik$$b1$$urwth
001007642 7001_ $$aSweet, Kendra$$b2
001007642 7001_ $$aApperley, Jane F.$$b3
001007642 7001_ $$aCortes, Jorge E.$$b4
001007642 773__ $$0PERI:(DE-600)1458429-3$$a10.1007/s00277-024-05851-4$$n9$$p3429-3442$$tAnnals of hematology$$v103$$x1432-0584
001007642 8564_ $$uhttps://publications.rwth-aachen.de/record/1007642/files/1007642.pdf$$yOpenAccess
001007642 909CO $$ooai:publications.rwth-aachen.de:1007642$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
001007642 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06025$$aRWTH Aachen$$b1$$kRWTH
001007642 9141_ $$y2024
001007642 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
001007642 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-27
001007642 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-27
001007642 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-27
001007642 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-27
001007642 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-27
001007642 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bANN HEMATOL : 2022$$d2024-12-27
001007642 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-27$$wger
001007642 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-27
001007642 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-27
001007642 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-27
001007642 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001007642 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001007642 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-27
001007642 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-27
001007642 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-27
001007642 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-27
001007642 9201_ $$0I:(DE-82)531040-2_20140620$$k531040-2$$lKlinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)$$x0
001007642 961__ $$z2025-03-20
001007642 970__ $$aeva578696
001007642 980__ $$aI:(DE-82)531040-2_20140620
001007642 980__ $$aUNRESTRICTED
001007642 980__ $$aVDB
001007642 980__ $$ajournal
001007642 9801_ $$aFullTexts